Diagnostic Value of Flexible Spectral Imaging Color Enhancement (FICE) Plus Probe-based Confocal Laser Endomicroscopy (pCLE) for Minimal Change Esophageal Reflux Disease (MERD) Diagnosis
Primary Purpose
Gastroesophageal Reflux Disease
Status
Completed
Phase
Not Applicable
Locations
Thailand
Study Type
Interventional
Intervention
Endoscopy (FICE and pCLE)
Sponsored by
About this trial
This is an interventional diagnostic trial for Gastroesophageal Reflux Disease focused on measuring Diagnostic technique and procedure
Eligibility Criteria
Inclusion Criteria:
- age more than 18 year old
- no PPI therapy in previous 2 weeks and
- no esophageal tumor or stenosis or history of esophageal surgery.
Exclusion Criteria:
- bleeding tendency including decompensated cirrhosis, chronic kidney disease
- long term antiplatelets or anticoagulants,
- pregnancy or
- history of fluorescein allergy.
Sites / Locations
- King Chulalongkorn Memorial Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
GERD patient
Control
Arm Description
36 GERD patients without obviously abnormality were examined by FICE and then followed by pCLE to evaluate minimal change esophagitis
18 control patients were were examined by FICE and then followed by pCLE to evaluate minimal change esophagitis
Outcomes
Primary Outcome Measures
MERD diagnosis from FICE plus pCLE.
Interobserver agreement in pCLE for MERD diagnosis
Secondary Outcome Measures
Full Information
NCT ID
NCT02336100
First Posted
January 6, 2015
Last Updated
February 26, 2019
Sponsor
King Chulalongkorn Memorial Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02336100
Brief Title
Diagnostic Value of Flexible Spectral Imaging Color Enhancement (FICE) Plus Probe-based Confocal Laser Endomicroscopy (pCLE) for Minimal Change Esophageal Reflux Disease (MERD) Diagnosis
Official Title
Diagnostic Value of Flexible Spectral Imaging Color Enhancement (FICE) Plus Probe-based Confocal Laser Endomicroscopy (pCLE) for Minimal Change Esophageal Reflux Disease (MERD) Diagnosis
Study Type
Interventional
2. Study Status
Record Verification Date
February 2019
Overall Recruitment Status
Completed
Study Start Date
June 2011 (undefined)
Primary Completion Date
February 2012 (Actual)
Study Completion Date
June 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
King Chulalongkorn Memorial Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Gastroesophageal reflux disease (GERD) patients without obvious mucosal break by endoscopy were examined by FICE, followed by confocal. Validity scores for MERD diagnosis were analyzed.
Detailed Description
Thirty-six patients with suspected MERD (positive GerdQ but normal conventional endoscopy) and eighteen asymptomatic control were recruited. The new FICE (EPX-4450HD) was performed at non-magnified, x50, and x100 zoom levels. The criteria for positive FICE were; A) triangular indentation, B) punctuate erythema, C) villiform mucosa, or D) increased number of capillary vessel. At the same session, pCLE was applied to count the number of intrapapillary capillary loops (IPCLs) by using more than 5 IPCLs in 500x500 micron area as a criterion for MERD diagnosis. The validity scores of both modalities and interobserever agreement of pCLE interpretation was assessed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastroesophageal Reflux Disease
Keywords
Diagnostic technique and procedure
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Non-Randomized
Enrollment
36 (Actual)
8. Arms, Groups, and Interventions
Arm Title
GERD patient
Arm Type
Experimental
Arm Description
36 GERD patients without obviously abnormality were examined by FICE and then followed by pCLE to evaluate minimal change esophagitis
Arm Title
Control
Arm Type
Experimental
Arm Description
18 control patients were were examined by FICE and then followed by pCLE to evaluate minimal change esophagitis
Intervention Type
Device
Intervention Name(s)
Endoscopy (FICE and pCLE)
Intervention Description
FICE is Flexible Spectral Imaging Color Enhancement and pCLE is probe-based Confocal Lase Endomicroscopy
Primary Outcome Measure Information:
Title
MERD diagnosis from FICE plus pCLE.
Time Frame
8 months
Title
Interobserver agreement in pCLE for MERD diagnosis
Time Frame
8 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
age more than 18 year old
no PPI therapy in previous 2 weeks and
no esophageal tumor or stenosis or history of esophageal surgery.
Exclusion Criteria:
bleeding tendency including decompensated cirrhosis, chronic kidney disease
long term antiplatelets or anticoagulants,
pregnancy or
history of fluorescein allergy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rapat Pittayanon, MD
Organizational Affiliation
king
Official's Role
Principal Investigator
Facility Information:
Facility Name
King Chulalongkorn Memorial Hospital
City
Bangkok
State/Province
Patum Wan
ZIP/Postal Code
10330
Country
Thailand
12. IPD Sharing Statement
Learn more about this trial
Diagnostic Value of Flexible Spectral Imaging Color Enhancement (FICE) Plus Probe-based Confocal Laser Endomicroscopy (pCLE) for Minimal Change Esophageal Reflux Disease (MERD) Diagnosis
We'll reach out to this number within 24 hrs